2. Úvod
  3. Science
  4. Grants
  5. Apply
  6. Grants
  7. JPND

EU Joint Programme – Neurodegenerative Disease Research (JPND)

JPND logo

What is the JP Neurodegenerative Diseases?

The EU Joint Programme – Neurodegenerative Disease Research (JPND) is the largest global research initiative aimed at tackling the challenge of neurodegenerative diseases. JPND aims to increase coordinated investment between participating countries in research aimed at finding causes, developing cures, and identifying appropriate ways to care for those with neurodegenerative diseases. Therefore, a network of national funding organizations from interested countries, in partnership with the EC, regularly launches joint calls for multinational and multidisciplinary collaborative research projects to encourage collaboration between public and private research groups from academia and enterprises. The Czech research teams are supported by the MEYS (MŠMT). The current call is open on the topic of Mechanisms and measurement of disease progression in the early phase of neurodegenerative diseases. See more details in the JPND 2024 Call Summary  

Who can apply for the JP Neurodegenerative Diseases?

Consortia consisting of 3-6 partners (up to 7 partners when partner/s from under-represented countries - Hungary, Latvia, Poland, or Turkey - participate) from at least 3 different countries represented by a coordinator. Max. 2 partners from the same country in one consortium.

Why apply for the JP Neurodegenerative Diseases?

  • Strengthening existing & building new international research collaborations.
  • Project team members can develop their professional career & improve their skills.
  • Take advantage of the opportunity that the participation of Czech research groups in a project can be funded by the MŠMT grant.

When to apply for the JP Neurodegenerative Diseases?

The nearest call deadline is for JPND 2024 and parallel the MEYS call is on Tue 05 Mar 2024 12:00 (noon) CET Pre-proposals (IOCB deadline Tue 27 Feb 2024). Consortia proceeding to full proposal stage will be asked to submit these by Tue 25 Jun 2024 12:00 (noon) (IOCB deadline Fri 21 Jun 2024).

  Please inform the Project Office about your intention to apply as soon as possible.  
  Do not hesitate to contact us anytime for consulting, discussion or help.  

How to apply for the JP Neurodegenerative Diseases?

  1. Find and read programme guidelines:
  2. Identify relevant project partners and further team members you would like to work with. Negotiate and justify roles, activities and responsibilities of all partners in the project. Designate the main Project Coordinator of the consortium, who will be responsible for a submission of the joint proposal via electronic submission system.
  3. Contact the host institutions and negotiate the institutional support. For IOCB agreement with project submission request authorisation to submit the proposal via the internal electronic IOCB Project Proposal Approval System (PPAS). You must be either connected to the IOCB network or via the IOCB Virtual Private Network (VPN). Please, contact the Project Office.
  4. Together with other PIs elaborate the research idea. Work closely with the other PIs and allow time for others to review the draft proposal. The information given in the pre-proposal is binding.

    5. Role of the Project Partner

    P1) Discuss the proposal with all project partners and prepare your parts for the joint pre-proposal JPND application form - use template  .
    • Your name and affiliation;
    • Your budget overview (total costs per category and brief description);
    • Participate on preparation of the joint project description part.


    Role of the Project Coordinator
[...detail, rozbalit/skrýt]

C1) Register the joint project proposal in the electronic submission system and fill in online sections of the application.

C2) Coordinate the preparation of the offline joint proposal - use template  :

  • Part I: Synopsis: application details, the consortium and a scientific summary, keywords, disease/s addressed (max. 1 page).
  • Part II: Project description: scientific background, aim, hypothesis, transnational added value, work plan, methodology, expertise, ethical issues, references (max. 4 pages).
  • Part III: Budget overview –costs requested by each partner, brief description (max. 1 page).

C3) Finalize the offline application form (respect the format and length limitation of each section) and convert all parts to a single PDF document and upload it to the project account using the electronic submission system. Ensure that the data uploaded to the electronic system are identical with the data in the offline application form. Please be aware that the online data entry may be overloaded on the days of the deadlines. It is therefore recommended to submit the proposal and obligatory attachments in good time.

Be aware that eligible costs and funding provisions may vary according to the respective national/regional funding organizations’ regulations.

  1. Complete mandatory national application to the MEYS
    • Eligible Costs Specification (in €, using MEYS template   (applicant & Project Office)
    • Statutory Declaration (Project Office)

Deadline for submission of the joint Pre-proposal (done by the Project Coordinator) and national application to the MEYS is on on Tue 05 Mar 2024 12:00 (noon) CET Pre-proposals (IOCB deadline Tue 27 Feb 2024).

Timetable of the next steps:
  • Results of Pre-proposals assessment by end of May 2024 (the application template and guidelines for the Full-proposal stage will be provided only to the project coordinators of successful consortia).
  • Deadline for Full-proposal submission is on Tue 25 Jun 2024 (noon) CEST Full-proposals (IOCB deadline Fri 21 Jun 2024).
  • Final results will be announcement in Oct 2024.
  • The grant start date is expected early 2025.

IOCB

IOCB participation (1) in the JP Neurodegenerative Diseases

  • Jan Konvalinka: Alzheimer’s disease as a co-morbidity of chronic periodontitis with Porphyromonas gingivalis as a causative link between both diseases (6/2020 – 5/2023)